Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Aurobindo Pharma USA Inc. recalls Clorazepate Dipotassium Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Discoloration: Dotted and yellow spots on tablets
Products
  • Clorazepate Dipotassium Tablets
Where it was sold

Nationwide in the USA

Nationwide

Units affected
6909 bottles
About this recall
Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, NDC 13107-283-05, Rx Only, Distributed by Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.